Organovo (ONVO) Updates Investor FAQ
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/28/2026
- Wall Street ends mixed as investors focus on tech earnings
- Nvidia in talks with OpenAI to guarantee $250 billion financing for data center, WSJ reports
- ASML and U.S. chip stocks sink on report of China’s DUV breakthrough
- Why is Bernstein bullish on memory stocks after Samsung, Nvidia deals?
- Oil prices settle at lowest in over a week, as US pauses attacks on Iran
- BTIG Upgrades Outlook Therapeutics Inc. (OTLK) to Buy
- Carpenter Technology CEO Brian Malloy passes; Tony Thene returns as CEO
- Applied Digital (APLD) Tops Q4 EPS by 23c, Revenue Beats
- ASML and U.S. chip stocks sink on report of China’s DUV breakthrough
- BuzzFeed cuts 35% of workforce in restructuring move
Organovo Holdings, Inc. To Present at Cantor Fitzgerald Inaugural Healthcare Conference
June 23, 2015 4:05 PM EDTSAN DIEGO, June 23, 2015 /PRNewswire/ -- Organovo Holdings, Inc. (NYSE MKT: ONVO; "Organovo"), a three-dimensional biology company focused on delivering scientific and medical breakthroughs using 3D bioprinting technology, announced today that the company will present at the upcoming investor event, the Cantor Fitzgerald Inaugural Healthcare Conference, to be held in New York, July 8, 2015. Keith Murphy, Chairman and Chief Executive Officer, will deliver a company presentation. Mr. Murphy and Barry Michaels, Chief Financial Officer for Organovo, will be available for individual meetings with investors throughout the day.
Details of the presentations are as... More
